Results 61 to 70 of about 3,656,183 (130)

Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones

open access: yes, 2018
We review pharmacological chaperones used in lysosomal storage diseases, emphasizing medicinal chemistry approaches and mechanisms of action.
Patrícia Valentão   +2 more
core   +1 more source

Mitochondrial biogenesis is transcriptionally repressed in lysosomal lipid storage diseases [PDF]

open access: yes, 2019
Perturbations in mitochondrial function and homeostasis are pervasive in lysosomal storage diseases, but the underlying mechanisms remain unknown. Here, we report a transcriptional program that represses mitochondrial biogenesis and function in lysosomal
Fernandez-Mosquera, Lorena   +19 more
core   +1 more source

Lysosomal storage diseases and the blood-brain barrier

open access: yes, 2008
The blood-brain barrier becomes a crucial issue in neuronopathic lysosomal storage diseases for three reasons. Firstly, the function of the blood-brain barrier may be compromised in many of the lysosomal storage diseases and this barrier dysfunction may ...
Scarpa, M, Pontikis, C C, Begley, D J
core   +3 more sources

Oligonucleotide-based therapies for inherited metabolic diseases: some examples of their application in Lysosomal Storage Disorders

open access: yes, 2021
Invited speakerAbout oligonucleotide-based therapies for inherited metabolic diseases: some examples of their application in Lysosomal Storage Disorders.N/
Alves, Sandra
core  

Pompe Disease: New Developments in an Old Lysosomal Storage Disorder

open access: yesBiomolecules, 2020
Pompe disease, also known as glycogen storage disease type II, is caused by the lack or deficiency of a single enzyme, lysosomal acid alpha-glucosidase, leading to severe cardiac and skeletal muscle myopathy due to progressive accumulation of glycogen ...
Naresh K. Meena, Nina Raben
doaj   +1 more source

Lysosomal Storage Diseases: an overview

open access: yes, 2018
Lysosomal storage diseases (LSDs)are an heterogenous group rare inherited metabolic diseases caused by mutations mutations in proteins critical critical for lysosomal function.FCT PTDC/BIM-MEC/4762/2014N/
Alves, Sandra
core  

Recent advances in gene therapy for lysosomal storage disorders [PDF]

open access: yes, 2015
David PW Rastall,1 Andrea Amalfitano1,2 1Department of Microbiology and Molecular Genetics, 2Department of Pediatrics, College of Osteopathic Medicine, Michigan State University, East Lansing, MI, USA Abstract: Lysosomal storage disorders (LSDs) are a ...
Amalfitano A, Rastall DP
core  

Cardiac involvement in Lysosomal Storage Diseases

open access: yes, 2020
Lysosomal storage diseases (LSDs) include a heterogeneous group of rare, inborn, metabolic diseases characterized by deficiency of lysosomal enzymes or of other proteins involved in lysosomal function, leading to multi organ system substrates ...
Concolino D.   +12 more
core  

Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases

open access: yes, 2017
Lysosomal storage diseases (LSDs) are a heterogeneous group of rare inherited metabolic diseases that are frequently triggered by the accumulation of lipids inside organelles of the endosomal-autophagic-lysosomal system (EALS).
James C. Dodge
core   +1 more source

The endoplasmic reticulum, not the pH gradient, drives calcium refilling of lysosomes

open access: yeseLife, 2016
Impaired homeostasis of lysosomal Ca2+ causes lysosome dysfunction and lysosomal storage diseases (LSDs), but the mechanisms by which lysosomes acquire and refill Ca2+ are not known.
Abigail G Garrity   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy